Gallbladder cancer is a rare type of cancer that originates in the gallbladder, a small organ located beneath the liver. It is more common in women and often presents with nonspecific symptoms such as abdominal pain, bloating, and nausea.
Risk factors for gallbladder cancer include a history of gallstones, obesity, and certain genetic conditions. Treatment for gallbladder cancer typically involves a combination of surgery, chemotherapy, and radiation therapy, depending on the stage of the cancer.
All myeloma parents below 70 yrs of age must check for eligibility for transplant. Bone marrow transplant helps extend the life span by a few years.
Contact us at +91-8130077375
or visit our website https://t.co/9NuyTEPfwe
#cancerrounds#hematology#hematologist#myeloma
World Cancer Day is an international observance held on February 4th every year to raise awareness about cancer and to encourage its prevention, detection, and treatment.
Cancer Rounds is working with the same objective to prevent the loss of many lives of cancer patients. Since last year we have assisted thousands of patients to get the best treatment from across the country.
Studies showed that in HER-2 positive metastatic #breastcancer patients, trastuzumab with #chemotherapy improved overall survival outcomes compared with trastuzumab alone.
Read more at - https://t.co/JiuEkIUZhC
#Cancer#CancerResearch#Cancers
It was found that adjuvant therapy with pembrolizumab has improved disease-free survival after nephrectomy in renal cell carcinoma patients. Although trials are going on to predict efficacy and toxicity.
Read more at - https://t.co/XwxYyza6lF
#cancer#treatment#CancerResearch
Radiation boost on the surgical bed has reduced remission in early stage #breast#cancer patients. It is recommended to younger women, although the decision will be made by a #radiation#oncologist.
Read more about #radiationtherapy for #breastcancer - https://t.co/meup36WCkW
Futibatinib is a potential #drug for the #treatment of #metastatic intrahepatic cholangiocarcinoma based on the phase 2 #study which showed a 42% #response rate with some minute side effects.
Read more on: https://t.co/Je9dIG01hB
A recent randomized trial has shown that when compared to placebo, adjuvant nivolumab with ipilimumab improved the 4-year overall #survivalrate for #metastatic#melanoma. The adjuvant #therapy has shown recurrence-free survival.
Read more at -https://t.co/6ucNUXH4Kk
Doxorubicin with Trabectedin has shown progression-free survival in advanced-grade smooth tissue sarcoma as a first-line treatment compared to doxorubicin alone, with manageable toxicity.
Consult an oncologist today!
Read the full article at: https://t.co/Y6cKs3a9nx
We are more than proud to say that #CancerRounds is associated with Dr. Rahul Bhargava. It is a great pleasure to be a helping hand to #cancer patients to reach such great #doctors in our society.
#bloodcancer patients outside urban cities of India can now get a #bonemarrowtransplant done in their city. It has been possible due to long and positive efforts from @DrRahulBhargav1 to setup 13 #BMT centers across cities in north India like Patna, Banaras, Gorakhpur, Meerut,etc
This phenomenon has changed in the last 5 years through the continuous efforts of Dr. Rahul who planned to collaborate and execute the opening up of new #BMT centers making it possible for more patients to avail of life-saving #treatment and develop a new ecosystem in that city.